Observational studyPLoS neglected tropical diseases2026
Neuroleptospirosis in patients presenting with primary central nervous system infection: A multicentre study.
Observational study in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLeptospirosis is well-known to cause neurological involvement. However, data on the frequency of neuroleptospirosis as a cause of primary central nervous system (CNS) infections is sparse. METHODOLOGY/PRINCIPAL
findingsAn observational study was conducted in three regions in Sri Lanka between October 2021-March 2024. Patients with a primary diagnosis of meningitis, meningoencephalitis or encephalitis were recruited. Blood and cerebrospinal fluid (CSF) were analysed for pathogenic Leptospira DNA by real-time PCR, and serology by microscopic agglutination test (MAT) on admission and after 10-14 days. A confirmed case was a patient with evidence of CNS infection with positive CSF or blood PCR and/or 4-fold rise/single titre ≥1:320 in MAT. A total of 100 patients were studied with a median age of 55 (IQR 39.7 - 69.7) years and 52 (52%) males. Suspected clinical diagnoses were meningitis (n = 66,66%), meningoencephalitis (n = 22,22%) and encephalitis (n = 12,12%). Eleven (11%) patients were laboratory-confirmed as neuroleptospirosis; meningitis (n = 3), meningoencephalitis (n = 3), encephalitis (n = 5). Three patients had positive blood Leptospira PCR, one had positive blood and CSF Leptospira PCR, three had high initial MAT and four had a 4-fold rise in MAT. Neurological manifestations included headache (n = 8), seizures (n = 2), confusion (n = 7), photophobia (n = 4), neck stiffness (n = 6) and limb weakness (n = 5). Majority of patients with positive blood or CSF PCR for Leptospira (n = 3, 75%) did not have a CSF cellular reaction. The neuroleptospirosis group had a lower requirement for intensive care compared to other CNS infections (9% vs 13.5%) and recovered without residual neurological disability. There were no deaths in the neuroleptospirosis group compared to 11 (12.4%) deaths in other CNS infections.
conclusionsLeptospirosis is an important cause of primary CNS infections, and may lead to more favourable outcomes. It is important to consider leptospirosis as an aetiological agent in the laboratory workup of primary CNS infections in leptospirosis-prevalent settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.